Don’t Jump to Suzetrigine for Acute Pain
Resources
- Chart: Analgesics for Acute Pain in Adults
- Other: Suzetrigine (Journavx)
March 2025 Issue
CE & Training
NEW REQUIRED COURSE: Substance Use Disorders and Pain Management: MATE Act Training
CE-IN-THE-LETTER: Prescriber Insights March 2025
LIVE CE: Meds for Opioid Use Disorder: Buprenorphine and Beyond
PODCAST CE: Medication Talk - Bronchitis and Pneumonia Treatment
GO TO CE & TRAINING ORGANIZERFeatured Clinical Resources
What is Prescriber's Letter?
Prescriber's Letter is the fastest, most trustworthy way to find out how drug therapy changes should fit into your practice, all while earning monthly CME credit. It's 100% free from financial support of the pharma industry. Learn more >
Unlock More
Prescriber's Letter is one of many medication advisory, CE, and training solutions from TRC Healthcare. We support prescribers of all kinds, at all stages of their career.
If you're a training decision-maker, learn more about our:
- Solutions for Group Practices
- Patient Simulations to Standardize Clinical Practice
Group Purchases & Pricing
Prescriber's Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information